We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients

By MedImaging International staff writers
Posted on 06 Mar 2024
Print article
Image: Preoperative and postoperative PSMA-PET/CT images showing removal of positive pelvic lymph nodes in radioguided surgical procedure (Photo courtesy of M.G.M. Schilham)
Image: Preoperative and postoperative PSMA-PET/CT images showing removal of positive pelvic lymph nodes in radioguided surgical procedure (Photo courtesy of M.G.M. Schilham)

In patients newly diagnosed with prostate cancer, the presence and location of lymph node metastases are critical for guiding clinical decisions and planning treatment. This is because nodal involvement is associated with the recurrence of the disease. Identifying these metastases can significantly benefit patients, enabling them to receive adjuvant therapies like radiation and chemotherapy, which can enhance their outcomes. Currently, extended pelvic lymph node dissection (ePLND) is regarded as the most effective method for nodal staging. This surgical procedure aims to remove as many metastatic lymph nodes as possible from the pelvic region. While the therapeutic impact of ePLND in prostate cancer remains a subject of debate, there's evidence suggesting that removing all nodal metastases could lead to optimal control of the disease in the local and regional areas.

Now, a new study by researchers at the Radboud University Medical Centre (Nijmegen, Netherlands) has revealed that radioguided surgery is capable of detecting and extracting metastatic pelvic lymph nodes in patients newly diagnosed with prostate cancer. This technique focuses on the prostate-specific membrane antigen (PSMA), commonly overexpressed in prostate cancer cases, enhancing nodal staging and thereby aiding in forming treatment strategies for this crucial patient group. The study incorporated 20 newly diagnosed patients with prostate cancer, each with at least one lymph node suspected of metastasis based on a preoperative 18F-PSMA PET/CT scan. They underwent 111In-PSMA-radioguided surgery to remove the metastatic nodes, followed by a postoperative 18F-PSMA PET/CT scan confirming the successful excision of these lesions. This study was crucial in evaluating the safety and practicality of 111In-PSMA-radioguided surgery and its precision in identifying metastatic lymph nodes.

The study reported no adverse events linked to the 111In-PSMA-radioguided surgery. In the procedure, 29 out of 49 lesions were identified and excised, with 28 of them (97%) confirmed to be lymph node metastases. Additionally, 14 out of the 49 (29%) removed lymph nodes, which were not identified by the radioguided surgery, included two that had metastases. Although previous research has examined the feasibility of PSMA-radioguided pelvic lymph node surgery, this study is among the first to explore this method in a larger cohort of newly diagnosed patients. The results underscore the safety and feasibility of this innovative surgical technique. Importantly, each patient underwent postoperative imaging, a vital step in confirming the reliability of the outcomes.

“The current results demonstrate the great potential for radioguided surgery in prostate cancer and highlight the expanding role of molecular imaging at the operating room,” said Mark Rijpkema, PhD, principal investigator at the Radboud University Medical Centre. “Optimization of tracers and larger clinical trials may further improve surgical outcomes in the future by implementing both measurements of removed tissue, as well as real-time measurements during surgery.”

Related Links:
Radboud University Medical Centre

New
Gold Member
X-Ray QA Meter
T3 AD Pro
Racks
Transducer Storage Racks and Stabilizers
New
Gold Member
X-Ray QA Meter
T3 RG Pro
New
Multi-Use Ultrasound Table
Clinton

Print article
Radcal

Channels

Radiography

view channel
Image: The CT scanner prototype eliminates the need for physical compression of the breast (Photo courtesy of Quion Lowe and Lisa Dahm/U of A Cancer Center)

Novel Breast Cancer Screening Technology Could Offer Superior Alternative to Mammogram

Breast cancer represents 15.5% of new cancer cases and 7% of cancer-related deaths in the United States. Approximately 13.1% of women will be diagnosed with breast cancer during their lifetime.... Read more

Ultrasound

view channel
Image: Wearable ultrasound device offers continuous, long-term monitoring of muscle activity (Photo courtesy of Muyang Lin/UC San Diego)

Wearable Ultrasound Device Provides Long-Term, Wireless Muscle Monitoring

Electromyography (EMG) is the current clinical standard for monitoring muscle activity, utilizing metal electrodes placed on the skin to capture electrical signals from muscles. Despite its long-standing... Read more

General/Advanced Imaging

view channel
Image: Heavy smokers can ben Image (2):	efit from lung cancer screening using low-dose CT (Photo courtesy of 123RF)

Low-Dose CT Screening for Lung Cancer Can Benefit Heavy Smokers

Lung cancer is often diagnosed at a late stage, with only about one-fifth to one-sixth of patients surviving five years after diagnosis. A new report now suggests that low-dose computed tomography (CT)... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The advocacy partnership aims to help accelerate access to life-saving treatments (Photo courtesy of Philips)

Philips and Medtronic Partner on Stroke Care

A stroke is typically an acute incident primarily caused by a blockage in a brain blood vessel, which disrupts the adequate blood supply to brain tissue and results in the permanent loss of brain cells.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.